MedTrace Logo

A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary

NCT02014519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2019-11-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to perform an epidemiological survey of the adult population in Hungary to calculate the seroprevalence of pertussis.

Conditions

  • Pertussis
  • Pertussis Vaccines

Interventions

PROCEDURE

Blood sampling

A blood sample (2.5 mL) will be collected from all subjects

OTHER

Data collection

Active questioning

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-24
Primary Completion
2015-04-22
Completion
2015-04-24

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014519 on ClinicalTrials.gov